Patho Flashcards
NSAIDs
- Indication
- DO NOT prevent or slow joint destruction
- Provide some sx relief, not appropriate for monotherapy & should only be used in conjunction w/ DMARDs
Corticosteroids
- Indication
- Potent anti-inflammatory agents that can slow down the progression of joint damage in RA
- Due to its SEs when use in long term
=> Reserved for brief periods of active disease
Bridge therapy use until DMARDS take effect
- Low dose Prednisone 5-10mg
Rayos
- Formula
- Administration
Prednisone Delayed-Release
- F: 1, 2, 5 mg tab
- Take w/ FOOD = incr absorption
- The shell breaks open= releases ~ 4H after adm
=> RayOs => O => take w/ FOOD
Ridaura
- Form
- Dose
- SEs
- Monitor
Auranofin = gold salt
- Form: PO
- Dose: 3mg BID or 6mg QD PO
- SEs: Itchy rash, mouth ulcers, diarrhea, flushing, vasodilation
Monitoring
- CBC Q3M
- UA Q3M for PO
Myochrysine
- Indication
- Route of adm
- SEs
- Monitoring
Gold sodium thiomalate = gold salt
- Indication: RA
- Dose: IM
SEs IM - Pruritic rash 20%, Stomatitis - Proteinuria - BMS/Leucopenia, thrombocytopenia, anemia - Nitroid rxn, flushing (vasodilation) - HypoTN => tachycardia => gOld => O => hypOtn
Monitoring
- CBC Q3M
- UA Q3M for PO
Rheumatrex
Trexall
- Form
- Indications
Methotrexate
- Form: PO
Indications:
- Ectopic pregnancy
- Psoriasis
- Chemotherapy
- RA
Arava
Leflunomide
Imuran
Azathioprine
Cuprimine
D- Penicillamine
Plaquenil
Hydroxychloroquine
Azulfidine
Azulfidine EN-tabs
Sulfazine
Sulfazine EC
- Indication
Sulfasalazine
- UC
- RA
Xeljanz
Tofacitinib
Toe fa SYE tin nib
Kineret
- Indication
Anakinra
- Indication: RA, Neonatal-onset multisystem inflammatory disease (NOMID)
Enbrel
Etanercept
Remicade
Infliximab
Humira
Adalimumab
A da LIM YOO mab
Simponi
Golimumab
Cimzia
Certolizumab
Cer to LIZ u mab
Orencia
Abatacept
Rituximab
Rituxan
Actemra
Tocilizumab
Golimumab
- Form:
Simponi-SC
Simponi Aria - IV
Methotrexate
- MOA
=> what it’s is
=> Work on which phase - Indications
MOA
- Antimetabolite chemotherapy (cell cycle specific)
- S-phase toxin (DNA synthesis phase)
- Folic acid structural analog
- Completely inhibits dihydrofolate (DHF) reductase
- Inhibits de novo pyrimidine synthesis
Indications
- Cancer Chemo
- Ectopic pregnancy (terminate pregnancy)
- Psoriasis
- RA
Methotrexate
- Dosing for RA
=> Initial
=> Max
=> Rec take supplement
Rheumatrex, Otrexup, Trexall
Dosing - Initial: 7.5mg PO single dose - 2.5mg PO Q12H x 3 doses given as a course QW - Max: 20mg/W - Supplement: 1mg/d Folate => 1mg is Rx. 0.4 and 0.8 mg is OTC
Methotrexate
- SEs
- Monitor
SEs
- Oral ulcer & stomatitis
- GI = N/diarrhea => most common
- Hepatotoxicity
- Renal
- Pulmonary fibrosis (CXR)
- Hypersensitivity pneumonitis: dry cough, fever, dyspenia. If so, stop MTX, exclude infection and start corticosteroids
- Myelo-supression/thombo-cytopenia: minimal compare to imuran, cytoxin, sandiummune
Monitor => obtain baseline
- CBC (WBC & plt Q4W)
- CXR
- LFT (Q3-4M)
- Renal fxn
Methotrexate
- Absolute CI
- Relative CI
Absolute CI
- Preg Cat X and lactating W
- Renal insuffiency SrCr > 1.5
- Pleural effusion
- Active stomatitis
- Diarrhea or any infection
- Immuno-deficiency
Relative CI
- Alcohol use or liver disease
- Age > 70 => as pt age, renal decre
Methotrexate
- Antidote
- Leucovorin
Leflunomide
- MOA
- Dose
- ADEs
- Monitor
=> How long?
Arava
MOA
- Inhibits dihydroorotate dehydrogenase
- Inhibitor of T-cell activation and proliferation
Dose
- LD: 100 mg PO QD x 3d
- MD: 10-20mg PO QD
ADEs
- Nausea
- Alopecia
- Increase LFT (CI in imp liver fxn)
Monitor:
- LFT: ALT/ALT QM x 6M.
Then Q8W thereafter (2Months)
- CBC
Leflunomide - Arava
- Wash out period
=> T1/2
=> Antitode
- T1/2 life: 2wks
Wash out period for:
- Switch to a different DMARD
- Hepatotoxiciy
- Wish to have children
Antitode
=> Cholestyramine 8grams TID for 11 days
Leflunomide - Arava
C/I
- Impair liver fxn
- Pregnancy Cat X
Azathioprine - Imuran
- MOA
- Indication
- Dosing
- CI
=> Preg Cat - DDI
- MOA: Purine analog => antimetabolite converts to 6MP
- I: RA, renal transplatation
- D: 100-150 mg PO QD / 1-2.5 mg/kg/d
- CI: Pregnancy Cat D and lactation
- DDI: allopurinal (Aloprim, Zyloprim)
Azathioprine - Imuran
- ADEs
- Cause severe which ADEs?
=> check CBC how often
SEs
- Myelosuppression: thrombocytopenia, anemia, leukopenia
- Skin rash
- Hepatotoxicity
- Flu-like sx, fever
- GI sx - severe N/V
D-Penicillamine - Cuprimine
- MOA
- Indication
- Dose
=> take with what? - CI
- MOA: Lowers IgM Rheumatoid factor by unknown MOA
Indication
- RA: 3rd line DMARD agent)
- Wilson’s disease (Incr copper): promote excretion of excess copper
Dose
- Start low, increase slowly
- Take on EMPTY STOMACH
- MD:750-1000 mg PO QD
CI: penicillin allergy
D-Penicillamine - Cuprimine
- ADEs
SEs - GI: Nausea - Dysgeusia: taste change & metallic taste - Rash/hypersensitivity, Stomatitis - Myelosuppression - Autoimmune disease => must d/c if have myasthenia gravis & lupus - Proteinurea; renal toxicity
HydrOxychloroquine - Plaquenil
- Indication
- Dose/Administration
Indication
- Early RA
- Malaria
Dose
- 200-400 mg PO QD with FOOD or milk
Sulfasalazine - Azulfidine
- MOA
- Indication
- Dosing for RA
=> Given when?
- MOA: inhibit of folate synthesis
Indication
- UC: Ulcerative colitis
- RA (Azulfidine EN only)
Dosing for RA
- 500 mg EC DR QD-BID after meals
- Increase to 1g PO BID
Dosing for Colitis
- 500-1000 mg PO QID
Sulfasalazine - Azulfidine
- SEs
- Monitoring
- CI
ADEs
- Rash/HA/GI upset
- Myelosuppression: check CBC
- Orange-yellow discoloration
- Fertility impairment
Monitoring
- CBC, LFT, hypersensitivity rxn
CI
- Sulfonamide or salicylate sensitivity
Tofacitinib - Xeljanz
- MOA
- Indication
=> Do not combine with - Dosing route
=> Renal/hepatic imp - SEs
=> D/c lymphocyte decr:
=> Check ? B/4 use: - DDI
- MOA: Janus kinase inhibitor
Indications
- RA pt decr response to or intolerate to MTX
- Do not combine w/ ABX or immunosuppressants
Dosing
- 5mg PO BID
- Decr to 5mg PO QD in mod/severe renal/hepatic imp or receiving inhibitor 3A4 or 2C9
SEs
- Infection
- D/c if lymphocyte count less than 500
- check TB prior to use
DDI
- 3A4 and 2C9 substrate
AnakINra - KineRET
- MOA
- Indication
- Route
- Storage
- SEs
=> Do not use in: - Monitor
=> RET: Lanh => fridge
=> in = Interleukin
- MOA: interleukin-1 receptor antagonist
- I: RA, Neonatal-onset multisystem inflammatory disease (NOMID)
- D: 100 mg SC QD
- S: refridgerate and protect from light
ADEs - Infectious: neutropenia - Pulmonary infections (COPD) - HA => DO NOT use in active infection or w/ TNF blockers etancercept, infiximab, adalimumab, abatacept - Injection site rash
Monitor
- CBC for neutrophil count
Etanercept - Enbrel
- MOA
- Indication
- Route and Frequency
- ADEs
- ALLs
- MOA: TNF receptor blocker
=> rapid onset & very effective
=> Good synergic effect w/ MTX
Indications
- RA => combine w/ MTX of DMARDs
- Psoristic arthritis
- Plaque psoriasis
Dosing
- 50 mg SQ QW in thigh, abdomen, upper arm
ADEs
- Potential risk of infection
ALL
- Needle contains latex
Etanercept - Enbrel
3 rec SC injection sites
- Front of middle thigh
- Abdomen
- Outer area of upper back arms
Infliximab - Remicade - MOA - Indication - Dose => route - Storage - CI
=> I => given IV
- MOA: Anti-TNF alpha monoclonal antibody
Indications
- Crohn’s D
- Ulcerative Colitis
- Plaque psoriasis
- Psoriatic arthritis
- Refractory RA: added to MTX or other agents
Dose for RA
- Initial 3mg/kg IV at 0 wk, 2 wks, 6 wks
- MD: 3mg/kg Q8W (6x every year)
S: Refrigerate
CI:
- TB (check PPD), histoplasmosis, coccidiomycosis
- Avoid live vaccines
Infliximab - Remicade
- ADEs
ADEs
- *Serious Life threatening infection
- Fever
- *May Worsen HF
- *Increase risk of malignancy
- HA
- Dyspnea
- Nausea
- Abdominal pain
- Optic neuropathy
Adalimumab - Humira
- MOA
- Indication
- dosing
=> W/ MTX
=> w/o MTX - Storage
- MOA: Monoclonal antibody - TNF blocker
Indications
- RA: alone or w/ MTX
- Psoriatic arthritis in adults
- Ankylosing spondylitis (AS) in adults (spine is straight & inflamed)
- Crohn’s D in adult
Dosing
- 40 mg SC QOW if on MTX OR
- 40 mg SC QW if not on MTX
Storage
- Refrigerate and protect from light
Adalimumab - Humira
- ADEs
- Warning
=> Dont combine w/:
=> May worsen - Monitoring
- Notes
SEs
- Infection: TB, virus, fungi, bacteria
- BMS: aplastic anemia, thrombocytopenia, leukopenia
- Cancer
- HF
- Lupus like syndrome
Warnings
- Dont combine w/ Anakinra => serious infection
- May worsen HF
Monitor
- CBC
Notes
- Avoid live vaccines => true for all TNF blockers
Adalimumab - Humira
Rec site to SC
- Front of thighs
- Abdomen (2 inches away from belly button)
Golimumab - Simponi SC and Simponi Aria IV
- Indications
- MOA
- BBW
- Route and Frequency
- ADEs
Indication
- RA: combine w/ MTX
- Psoriatic arthritis
- Ankylosing spondylitis : arthritis of spine
MOA
- Target and neutralizes TNF-alpha
BBW
- BBW risk of TB invasive fungal infection (histo, cocci)
Dose
- 50 mg SC once a month (self injected)
- Simponia Aria: 2mg/kg IV over 30 min at weeks 0, 4 and then Q8W
SEs
- URI, sore throat, nasal congestion
Certolizumab - Cimzia
- Indications
- MOA
- CI: same as others
- Route and frequency
- SEs
Indications
- RA
- Crohn’s D
MOA
- TNF inhibitor
CI
- Same as other TNF inhibitors
Dose:
- 400 mg SC at wk 0, 4 followed by 200 mg QOW or 400 mg Q4W
SEs
- Serious infections
- Malignancies
- HF
Abatacept - Orencia
- MOA
- Indications
- Route
- SEs
- avoid
3A => infusion over 30 min
MOA
- Inhibits production of tumor necrosis factor, interleukin-2 and interferon-gamma
Indications
- RA: for who don’t response to TNF blockers or DMARDs
Dosing
- 30 min IV infusion
SEs
- CoPD watch for exacerbation
- Pulmonary infection
- Malignancies
=> avoid live vaccine
Rituximab - Rituxan
- MOA
- Indication
- Dosing
=> Premedicate - Storage
- CI
MOA
- Monoclonal antibody directly against CD20 on B cells
Indications
- Refractory RA
- Non-Hodgkins Lymphoma
- Microscopic polyangiitis (MPA$
Dosings
- RA: 1g IV Q2W x 2 doses
=> Premedicate w/ methylprednisolone 100 mg IV
Storage:
- refrigerate away from light and moisture
CI
- Live virus vaccines
- Allergy to murine proteins
Rituximab - Rituxan
- SEs
- Monitor
SEs - Severe infusion rxn: infuse w/in 30-120min => use methylprednisolone 100 mg IV 30 min prior to infusion - Tumor lysis syndrome: leading to ARF - HTN - Hepatitis B reactivation - Nephrotoxicity - URI
Monitoring
- PPD: before initiating
- CBC
Tocilizumab - Actemra => IV Q4W (once a month) - MOA - Indication - Doses => Dilute with: - Warning => Dont combine with: => Do not start if:
MOA
- Interleukin-6 (IL-6) receptor inhibitor
- Indication: RA pts w/ inadequate response to 1 or more TNF blockers
Doses
- Single vials IV => dilute to 100mL 0.9% NaCl
- 4mg/kg - 8mg/kg Q4W.
- Max: 800 mg/H IV infusion
Warnings
- Serious infections: don’t combi w/ biological DMARDS
- Anaphylaxis or serious hypersensitivity rxns
- Live vaccines NOT to be given w/ actemra
- Do not start if:
=> ANC Plt ALT/AST > 1.5 x ULN
Five TNF blockers are:
- Adalimumab (Humira) 40mg SC QOW
- Etanercept (Enbrel) 50 mg SQ QW
- Infliximab (Remicate) IV infusion Q8W
- Simponi (Golimumab) SC once a month
- Cimzia (Certolizumab) SQ once or twice a month
T cell activator inhibitor
- Abatacept (Orencia): IV infusion once a month
CD20 monoclonal antibody
Rituxan (Rituximab) TWO 1000 mg IV infusion separate by two weeks
When use TNF blockers, always rec
=> Caution
=> CI
- PPD test for TB before start therapy
Caution
- TNF blocker can worse HF
- Avoid live vaccines
- Avoid Interleukin -1 receptor blockers:
CI
- TB
- Histoplasmosis
- Coccidiomycosis
For all DMARDS
- Check wat
Check CBC for all
Monitoring
- Gold
- Methotrexate
- Leflunomide - Arava
- Azathioprine - Imuran
- D-Penicillamine - Cuprimine
- Hydroxychloroquine - Plaquenil
- Sulfsalazine - Azulfidine
- Anakinara - Kineret
- Adalimumab - Humira
- Rituximab - Rituxan
Gold
- CBC Q3M
- UA Q3M for PO
Methotrexate
- CBC: WBC & Plt check Q4W
- CXR
- LFT: check Q3-4M
- Renal fxn
Leflunomide - Arava
- LFTs: QM x 6M. Thereafter Q2M
Azathioprine - Imuran
- CBC & Plt Q1-2W w/ changes of dose & ten Q1-3M thereafter
D-Penicillamine - Cuprimine
- CBC
Hydroxychloroquine - Plaquenil
- Plaque in eye => Eye exam Q6-12M
Sulfsalazine - Azulfidine
- CBC: Check Q2-4W x 3M then Q3M
- LFT
- Hypersensitivity rxn
Anakinara - Kineret
- CBC for neutrophil count
Adalimumab - Humira
- CBC
Rituximab - Rituxan
- PPD
- CBC
Which medications should worry about latex allergy
- Etanercept - Enbrel
- Needle cover contains latex
Need Refrigerate
- Etanercept - Enbrel
- Infliximab - Remicade
- Adalimumab - Humira
- Rituximab - Rituxan
Protect from light
- Adalimumab - Humira
- Rituximab - Rituxan => and moisture
Cause Lupus like syndrome
- Adalimumab - Humira
Worsen HF
- Inflixmab - Remicade
- Adalimumab - Humira
- Certolizumab - Cimzia
Which has ankylosing spondytitis indication
- Adalimumab - Humira
- Golumumab - Simponi
BBW for risk of TB invasive fungal infections
- Golumumab - Simponi
Use for Refractory RA
- Infliximab - Remicade
- Rituximab - Rituxan
=> Abatacept - Orencia => for who don’t respond to TNF blockers or other DMARDs
=> Tocilizumab - Actemra => for pt w/ inadequate response to 1 or more TNF blockers
CI in murine proteins allergy
- Rituximab - Rituxan
Anaphylaxis Rx
- Tocilizumab - Actemra
Rasuvo
- Indication
- Form
MTX
- I: RA and severe psoriasis
- Form: preservative free SQ weekly
Otrexup
- Form
MTX
- Form: auto injection